| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.075 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |